Correlation Between Werewolf Therapeutics and Merus BV

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Werewolf Therapeutics and Merus BV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Werewolf Therapeutics and Merus BV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Werewolf Therapeutics and Merus BV, you can compare the effects of market volatilities on Werewolf Therapeutics and Merus BV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Werewolf Therapeutics with a short position of Merus BV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Werewolf Therapeutics and Merus BV.

Diversification Opportunities for Werewolf Therapeutics and Merus BV

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Werewolf and Merus is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Werewolf Therapeutics and Merus BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merus BV and Werewolf Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Werewolf Therapeutics are associated (or correlated) with Merus BV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merus BV has no effect on the direction of Werewolf Therapeutics i.e., Werewolf Therapeutics and Merus BV go up and down completely randomly.

Pair Corralation between Werewolf Therapeutics and Merus BV

Given the investment horizon of 90 days Werewolf Therapeutics is expected to under-perform the Merus BV. In addition to that, Werewolf Therapeutics is 2.01 times more volatile than Merus BV. It trades about -0.26 of its total potential returns per unit of risk. Merus BV is currently generating about -0.24 per unit of volatility. If you would invest  5,192  in Merus BV on August 30, 2024 and sell it today you would lose (695.00) from holding Merus BV or give up 13.39% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Werewolf Therapeutics  vs.  Merus BV

 Performance 
       Timeline  
Werewolf Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Werewolf Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Werewolf Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Merus BV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merus BV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Werewolf Therapeutics and Merus BV Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Werewolf Therapeutics and Merus BV

The main advantage of trading using opposite Werewolf Therapeutics and Merus BV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Werewolf Therapeutics position performs unexpectedly, Merus BV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merus BV will offset losses from the drop in Merus BV's long position.
The idea behind Werewolf Therapeutics and Merus BV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities